Global Cancer Diagnostics Market Size To Exceed USD 323.17 Billion By 2033

The Global Cancer Diagnostics Market is expected to grow significantly from USD 140.25 billion in 2023 to USD 323.17 billion by 2033, at a CAGR of 8.71%. This growth is primarily driven by the rising number of cancer cases worldwide, advancements in cancer diagnostics, the use of biomarkers, and the application of AI in cancer diagnosis.

Cancer diagnosis involves identifying proteins and biomarkers that indicate the presence of cancerous growth. Unhealthy lifestyles, smoking, diabetes, and excessive alcohol consumption contribute to the increase in mortality due to various forms of cancer.

The imaging segment dominates the market due to the non-invasive, quick, and painless diagnostic processes like magnetic resonance imaging and computed tomography scans. These imaging modalities are useful in cancer staging and monitoring metabolic and functional data by therapeutic and prognostic systems.

The breast cancer segment is expected to grow rapidly due to public awareness campaigns by organizations such as the National Breast Cancer Foundation, Inc. Diagnostic laboratories dominate the market, driven by the increasing need for affordable services, rising awareness of personalized medicine, and technological advancements.

North America dominates the market due to the presence of biotechnology and medical device companies, increasing R&D expenditures, FDA approvals, strategic collaborations, and sizeable investment in R&D. The Asia-Pacific region is expected to grow rapidly due to a large patient base, affordable access to skilled technicians, a supportive regulatory framework, and an increase in medical tourism.

Key players in the Global Cancer Diagnostics Market include Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, QIAGEN N.V., Roche Diagnostics, Philips Healthcare, BioMérieux SA, Volpara Solutions Limited, Canon Medical Systems Corporation, BioNTech Diagnostics GmbH, Agilent Technologies, Inc., Illumina, Inc., GE Healthcare, Abbott Laboratories, Inc., Siemens Healthcare, and others.

.st1{display:none}See more